Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy? (Record no. 30373958)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01411 a2200385 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518072736.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202106s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1463-1326 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1111/dom.13938 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Inzucchi, Silvio E |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20210624 |
| 245 00 - TITLE STATEMENT | |
| Title | Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy? |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Diabetes, obesity & metabolism |
| Date of publication, distribution, etc. | 04 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 631-639 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Benzhydryl Compounds |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cardiovascular Diseases |
| General subdivision | epidemiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Diabetes Mellitus, Type 2 |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Glucose |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Glucosides |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hypoglycemic Agents |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kidney |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fitchett, David |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jurišić-Eržen, Dubravka |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Woo, Vincent |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hantel, Stefan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Janista, Christina |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kaspers, Stefan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | George, Jyothis T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zinman, Bernard |
| 773 0# - HOST ITEM ENTRY | |
| Title | Diabetes, obesity & metabolism |
| Related parts | vol. 22 |
| -- | no. 4 |
| -- | p. 631-639 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1111/dom.13938">https://doi.org/10.1111/dom.13938</a> |
| Public note | Available from publisher's website |
No items available.